Navigation Links
HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia (BPH) Product
Date:6/25/2008

KING OF PRUSSIA, Pa., June 25 /PRNewswire/ -- HighPoint Solutions LLC, a premier provider of business-driven IT solutions, announced today it has been selected to develop an Incentive Compensation Plan for a new Benign Prostatic Hyperplasia (BPH) product currently under FDA approval review. With the project's completion targeted for late summer 2008, the goal of the compensation plan is to motivate the field sales force and ensure the alignment of tactical activities with the product's strategic goals and budgets.

HighPoint Solutions has partnered with Qforma, the leader in advanced analytics and predictive modeling for pharmaceutical companies, on the initiative. Using a physician target universe built from Qforma's iQMap(TM), HighPoint Solutions will develop the incentive compensation plans for the launch product across all levels of the organization to drive the product's success.

"Our client is launching its new product in a crowded marketplace where the gold standard drug is going generic in 2010. It is crucial that a plan is developed offering the right balance of motivation for the sales team and realistic product uptake, while remaining within the product's budget," explained Chris Colapietro, vice president of Strategy and Marketing at HighPoint Solutions.

Alan Reicheg, Qforma's senior vice president of Commercial Operations, added, "Advances in analytics are revealing customer behaviors and emerging market shifts that point to opportunities, which can be measured and quantified in the BPH market. This type of precision targeting is now benchmark technology and our client will use it to make well-informed, strategic sales and marketing decisions."

This project combines HighPoint Solutions' industry expertise with Qforma's advanced technologies, to uncover, interpret and utilize insights from prescribing and customer peer interactions present in large data sets -- ultimately increasing sales and marketing effectiveness while leveraging optimal efficiencies as programs critical to the success of the new BPH drug launch are planned and implemented.

About Qforma

Qforma is an advanced analytics and predictive modeling company specializing in sales and marketing solutions for the healthcare industry. Qforma leverages the talents of physicists, mathematicians and programmers, and has developed a unique approach to quantifying large disparate data flows with the purpose of eliminating the inefficiencies of traditional sales and marketing techniques.

Qforma is headquartered in Santa Fe, N.M., with offices in Bucks County, Pa., Princeton, N.J. and Boston Mass.

About HighPoint Solutions LLC

HighPoint Solutions is a premier provider of business-driven IT solutions to more than 50 clients nationwide in the life science, healthcare and financial industries. The company provides business consulting, system integration and professional services, including onsite industry-specialized IT staffing, offshore resources, managed hosting and application support services.

HighPoint is headquartered in King of Prussia, Pa. with additional offices in New Jersey and Chicago. For more information, visit http://www.highpoint-solutions.com.

Contact:

Karen Higgins

Sagefrog Marketing

(610) 831-5723

karenh@sagefrog.com


'/>"/>
SOURCE HighPoint Solutions LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HighPoint Solutions Signs Deal to Implement Model N Managed Care and Government Pricing System for Specialty Pharmaceutical Company
2. Critical Homecare Solutions Holdings, Inc. Reports Full Year 2007 and First Quarter 2008 Results
3. SXC Health Solutions announces three-year $35 million PBM contract with the State of Tennessee
4. Pioneering Solutions To Fight Staph, MRSA Infections in Sports Facilities and Synthetic Turf Fields
5. SXC Health Solutions to Present at the Jefferies 2nd Annual Healthcare Conference
6. AHIP Selects HealthTrio to Join AHIP Solutions Program
7. SXC Health Solutions announces Mark Thierer to be named President & CEO
8. DST Health Solutions(R) and Colorado Access Extend Agreement for Business Process Outsourcing Services
9. Microsoft to Showcase Innovative Solutions for Health Plans at AHIP Institute 2008
10. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
11. Elekta Launches Web-based Virtual Clinic, Offers Better Understanding of Radiotherapy Solutions for the Treatment of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be a result ... has helped many women become pregnant upon treating their diagnosis. , ... outpatient evaluations. We can provide the necessary information to diagnose and treat ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... expertise for sponsors and CROs to speed clinical development, has released the ... platform. Bioclinica AGILE RTSM provides seamless clinical supply forecasting and ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates ... Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition Duchenne ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new patients ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients can ... more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear ...
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from medical ... heartened by the industry’s current surge. But another thing that unifies them is a ... last they can simply, safely and effectively end their aroma anguish thanks to a ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... LONDON , April 19, 2017 ... to stimulate an immune response in pets such ... vaccine products are of various types such as ... Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. ... such as virus or bacteria, which have been ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: